Li XJ - Search Results

1

Neoadjuvant immunotherapy combined with chemotherapy in the treatment of stage III lung squamous cell carcinoma: a retrospective cohort study.

Guo J, Lin SD, Minervini F, Geraci TC, Kim JJ, Tong CY, Li XJ, Cao C. Guo J, et al. Among authors: li xj. J Thorac Dis. 2023 Oct 31;15(10):5658-5668. doi: 10.21037/jtd-23-1175. Epub 2023 Sep 12. J Thorac Dis. 2023. PMID: 37969291 Free PMC article.

2

Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer.

Shi J, Guo J, Li X. Shi J, et al. Int J Oncol. 2018 Jan;52(1):179-188. doi: 10.3892/ijo.2017.4201. Epub 2017 Nov 10. Int J Oncol. 2018. PMID: 29138807

3

Postpneumonectomy transthoracic Esophagectomy - a case report: using anatomic change to create Extrathoracic Esophagogastric anastomosis.

Li Q, Guo J, Li C, Li X. Li Q, et al. J Cardiothorac Surg. 2018 Jun 5;13(1):57. doi: 10.1186/s13019-018-0742-5. J Cardiothorac Surg. 2018. PMID: 29871681 Free PMC article.

4

Comprehensive Bioinformatics Analysis to Identify the Gene HMMR Associated With Lung Adenocarcinoma Prognosis and Its Mechanism of Action in Multiple Cancers.

Shi J, Chen Y, Wang Z, Guo J, Tong C, Tong J, Hu W, Li C, Li X. Shi J, et al. Front Oncol. 2021 Oct 6;11:712795. doi: 10.3389/fonc.2021.712795. eCollection 2021. Front Oncol. 2021. PMID: 34692489 Free PMC article.

5

Identification of a Three-Gene Signature Based on Epithelial-Mesenchymal Transition of Lung Adenocarcinoma Through Construction and Validation of a Risk-Prediction Model.

Shi J, Wang Z, Guo J, Chen Y, Tong C, Tong J, Hu W, Li C, Li X. Shi J, et al. Front Oncol. 2021 Oct 21;11:726834. doi: 10.3389/fonc.2021.726834. eCollection 2021. Front Oncol. 2021. PMID: 34745947 Free PMC article.

6

C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 7(CXCR7) regulates epithelial-mesenchymal transition process and promotes the metastasis of esophageal cancer by activating signal transducer and activator of transcription 3 (STAT3) pathway.

Guo J, Tong CY, Shi JG, Li XJ. Guo J, et al. Among authors: li xj. Bioengineered. 2022 Mar;13(3):7425-7438. doi: 10.1080/21655979.2022.2048984. Bioengineered. 2022. PMID: 35264069 Free PMC article.

7

Treatment paradigms and survival outcomes in esophageal adenocarcinoma with liver metastasis: a retrospective cohort study using the SEER database.

Guo J, Tong CY, Shi JG, Li XJ. Guo J, et al. Among authors: li xj. J Gastrointest Oncol. 2022 Jun;13(3):935-948. doi: 10.21037/jgo-22-420. J Gastrointest Oncol. 2022. PMID: 35837204 Free PMC article.

8

A 20-gene mutation signature predicts the efficacy of immune checkpoint inhibitor therapy in advanced non-small cell lung cancer patients.

Hu X, Guo J, Shi J, Li D, Li X, Zhao W. Hu X, et al. BMC Pulm Med. 2023 Jun 22;23(1):223. doi: 10.1186/s12890-023-02512-6. BMC Pulm Med. 2023. PMID: 37349743 Free PMC article.

9

Deletion of osteopontin in non-small cell lung cancer cells affects bone metabolism by regulating miR-34c/Notch1 axis: a clue to bone metastasis.

Guo J, Tong CY, Shi JG, Li XJ, Chen XQ. Guo J, et al. Among authors: li xj. Eur J Histochem. 2023 Jul 26;67(3):3631. doi: 10.4081/ejh.2023.3631. Eur J Histochem. 2023. PMID: 37491944 Free PMC article.

10

A prognosis model for predicting immunotherapy response of esophageal cancer based on oxidative stress-related signatures.

Guo J, Tong C, Shi J, Li X, Chen X. Guo J, et al. Oncol Res. 2023 Nov 15;32(1):199-212. doi: 10.32604/or.2023.030969. eCollection 2023. Oncol Res. 2023. PMID: 38196829 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,363 results

Search Page

Filters